130 related articles for article (PubMed ID: 38573165)
1. Novel Variant and Known Mutation in 23S rRNA Gene of Mycoplasma pneumoniae, Northern Vietnam, 2023.
Nguyen DD; Ho NT; Dover LG; Vo AHM; Ly HTT; Doan PM; Nguyen HT; Luu NTT; Pham AN; Tran HTT
Emerg Infect Dis; 2024 May; 30(5):1034-1036. PubMed ID: 38573165
[TBL] [Abstract][Full Text] [Related]
2. Differences in the frequency of 23S rRNA gene mutations in Mycoplasma pneumoniae between children and adults with community-acquired pneumonia: clinical impact of mutations conferring macrolide resistance.
Yoo SJ; Kim HB; Choi SH; Lee SO; Kim SH; Hong SB; Sung H; Kim MN
Antimicrob Agents Chemother; 2012 Dec; 56(12):6393-6. PubMed ID: 23006753
[TBL] [Abstract][Full Text] [Related]
3. Genotyping and macrolide resistance of Mycoplasma pneumoniae identified in children with community-acquired pneumonia in Medellín, Colombia.
Copete AR; Aguilar YA; Rueda ZV; Vélez LA
Int J Infect Dis; 2018 Jan; 66():113-120. PubMed ID: 29155089
[TBL] [Abstract][Full Text] [Related]
4. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
[TBL] [Abstract][Full Text] [Related]
5. Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia.
Deng H; Rui J; Zhao D; Liu F
J Int Med Res; 2018 Jan; 46(1):150-157. PubMed ID: 28760082
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
Choi JH; Seong GM; Ko Y; Kim YR; Kim C
Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
[No Abstract] [Full Text] [Related]
7. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N;
BMC Infect Dis; 2012 May; 12():126. PubMed ID: 22650321
[TBL] [Abstract][Full Text] [Related]
8. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
9. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
[TBL] [Abstract][Full Text] [Related]
10. Two cases of Mycoplasma pneumoniae pneumonia with A2063G mutation in the 23S rRNA gene in siblings.
Hong JH; Chun JK; Uh Y; Oh KJ; Kim J; Yoon KJ
Ann Lab Med; 2013 Jan; 33(1):65-8. PubMed ID: 23301225
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.
Zhao F; Lv M; Tao X; Huang H; Zhang B; Zhang Z; Zhang J
Antimicrob Agents Chemother; 2012 Feb; 56(2):1108-9. PubMed ID: 22106216
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of Macrolide-Resistant Mycoplasma pneumoniae from Children in Jeju.
Kim YJ; Shin KS; Lee KH; Kim YR; Choi JH
J Korean Med Sci; 2017 Oct; 32(10):1642-1646. PubMed ID: 28875608
[TBL] [Abstract][Full Text] [Related]
13. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
[TBL] [Abstract][Full Text] [Related]
14. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
Miyashita N; Oka M; ; Kawai Y; Yamaguchi T; Ouchi K
Int J Antimicrob Agents; 2010 Oct; 36(4):384-5. PubMed ID: 20674283
[No Abstract] [Full Text] [Related]
15. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.
Suzuki Y; Itagaki T; Seto J; Kaneko A; Abiko C; Mizuta K; Matsuzaki Y
Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374
[TBL] [Abstract][Full Text] [Related]
16. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Morozumi M; Iwata S; Hasegawa K; Chiba N; Takayanagi R; Matsubara K; Nakayama E; Sunakawa K; Ubukata K;
Antimicrob Agents Chemother; 2008 Jan; 52(1):348-50. PubMed ID: 17954691
[TBL] [Abstract][Full Text] [Related]
17. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011.
Hong KB; Choi EH; Lee HJ; Lee SY; Cho EY; Choi JH; Kang HM; Lee J; Ahn YM; Kang YH; Lee JH
Emerg Infect Dis; 2013 Aug; 19(8):1281-4. PubMed ID: 23876792
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of Mycoplasma pneumoniae infections in Moscow from 2015 to 2018.
Voronina EN; Gordukova MA; Turina IE; Mishukova OV; Dymova MA; Galeeva EV; Korsunskiy AA; Filipenko ML
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):257-263. PubMed ID: 31655931
[TBL] [Abstract][Full Text] [Related]
19. Development of an endpoint genotyping assay to detect the Mycoplasma pneumoniae 23S rRNA gene and distinguish the existence of macrolide resistance-associated mutations at position 2063.
Suzuki Y; Seto J; Shimotai Y; Ikeda T; Yahagi K; Mizuta K; Matsuzaki Y; Hongo S
J Microbiol Methods; 2016 Dec; 131():130-134. PubMed ID: 27789313
[TBL] [Abstract][Full Text] [Related]
20. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
